SPRY4 and neoplasm: Multivariate analysis of the three prognosis factors confirmed that a low SPRY4-IT1 expression level was an independent predictor of poor survival for NSCLC (P=0.009), in addition to tumor node metastasis stage (P=0.041) (Supplementary Table 3).